August VAERS Update

Aug 20, 2022

Nearly 30,000 Deaths Reported to VAERS, Including 17-Year-Old Who Died of Myocarditis 5 Months After Pfizer Shot

Key highlights:

U.S. VAERS data from Dec. 14, 2020, to July 29, 2022, for 6-month-olds to 5-year-olds show:

2,622 adverse events, including 81 cases rated as serious and 3 reported deaths.
4 reports of myocarditis and pericarditis (heart inflammation).The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
15 reports of blood clotting disorders.
25 reports of seizures.

U.S. VAERS data from Dec. 14, 2020, to July 29, 2022, for 5- to 11-year-olds show:

U.S. VAERS data from Dec. 14, 2020, to July 29, 2022, for 12- to 17-year-olds show:

63 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 97% of cases attributed to Pfizer’s vaccine.
658 reports of myocarditis and pericarditis with 645 cases attributed to Pfizer’s vaccine.
165 reports of blood clotting disorders with all cases attributed to Pfizer.
20 cases of postural orthostatic tachycardia syndrome (POTS) with all cases attributed to Pfizer’s vaccine.

U.S. VAERS data from Dec. 14, 2020, to July 29, 2022, for all age groups combined, show:

20% of deaths were related to cardiac disorders.
55% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
The average age of death was 73.
As of July 29, 5,684 pregnant women reported adverse events related to COVID-19 vaccines, including 1,777 reports of miscarriage or premature birth.
Of the 3,629 cases of Bell’s Palsy reported, 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.
907 reports of Guillain-Barré syndrome, with 42% of cases attributed to Pfizer, 30% to Moderna and 27% to J&J.
2,298 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
1,750 reports of myocardial infarction.
14,303 reports of blood-clotting disorders in the U.S. Of those, 6,401 reports were attributed to Pfizer, 5,145 reports to Moderna and 2,722 reports to J&J.
4,287 cases of myocarditis and pericarditis with 2,627 cases attributed to Pfizer, 1,456 cases to Moderna and 188 cases to J&J.
14 cases of Creutzfeldt-Jakob disease with 8 cases attributed to Pfizer, 5 cases to Moderna and 1 case to J&J.